NovaBridge Biosciences
NBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001778016
In the last 90 days, NovaBridge Biosciences insiders filed 0 open-market purchases and 4 sales; 49 institutions reported holding it in 13F filings for Q2 2026, worth $48.1M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in NovaBridge Biosciences as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −9 vs. Q2 2024
- Shares held
- 14.2M
- −938.9K (−6.2%) vs. Q2 2024
- Total value
- $17.6M
- −$7.72M (−30.5%) vs. Q2 2024
- New holders
- 4
- 5 more added
- Sold out
- 13
- 6 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 49 | $48.1M |
| Q1 2026 | 48 | $72.1M |
| Q4 2025 | 57 | $132.1M |
| Q3 2025 | 42 | $112.3M |
| Q2 2025 | 32 | $22.7M |
| Q1 2025 | 29 | $7.41M |
| Q4 2024 | 28 | $10.1M |
| Q3 2024 | 28 | $17.6M |
| Q2 2024 | 38 | $25.3M |
| Q1 2024 | 39 | $22.7M |
| Q4 2023 | 44 | $23.5M |
| Q3 2023 | 47 | $20.1M |
| Q2 2023 | 48 | $55.9M |
| Q1 2023 | 53 | $71.6M |
| Q4 2022 | 69 | $103.9M |
| Q3 2022 | 75 | $123.3M |
| Q2 2022 | 97 | $430.3M |
| Q1 2022 | 120 | $654.5M |
| Q4 2021 | 132 | $1.85B |
| Q3 2021 | 145 | $2.61B |
| Q2 2021 | 136 | $2.38B |
| Q1 2021 | 80 | $1.13B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding NovaBridge Biosciences; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 6,909,220 | $8.57M | 0.19% | 00.0% | Unchanged |
| Caligan Partners LP | 3,499,330 | $4.34M | 1.38% | +124,539+3.7% | Added |
| Boothbay Fund Management, LLC | 1,419,080 | $1.76M | 0.06% | +39,728+2.9% | Added |
| Temasek Holdings (Private) Ltd | 566,650 | $702.6K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 499,300 | $619.1K | 0.00% | −77,300−13.4% | Reduced |
| Two Sigma Investments, LP | 408,519 | $506.6K | 0.00% | −69,923−14.6% | Reduced |
| EDBI Pte Ltd | 222,136 | $275.4K | 0.37% | 00.0% | Unchanged |
| Standard Life Aberdeen plc | 162,580 | $201.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 98,389 | $122.0K | 0.00% | +59,681+154.2% | Added |
| Alberta Investment Management Corp | 74,723 | $92.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 63,800 | $79.1K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 58,358 | $72.4K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 43,039 | $53.4K | 0.00% | +25,163+140.8% | Added |
| Mariner, LLC | 31,535 | $39.1K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 30,647 | $38.0K | 0.00% | +16,767+120.8% | Added |
| Barclays PLC | 30,370 | $37.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 22,037 | $27.3K | 0.00% | −12,310−35.8% | Reduced |
| Susquehanna International Group, LLP | 13,351 | $16.6K | 0.00% | −17,715−57.0% | Reduced |
| Millennium Management LLC | 11,325 | $14.0K | 0.00% | −28,983−71.9% | Reduced |
| Goldman Sachs Group Inc | 10,685 | $13.2K | 0.00% | −5,065−32.2% | Reduced |
| Freestone Capital Holdings, LLC | 10,000 | $12.4K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 4,015 | $4.98K | 0.00% | +4,015 | New |
| BlackRock, Inc. | 1,438 | $1.78K | 0.00% | +1,438 | New |
| Rhumbline Advisers | 1,367 | $1.69K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,191 | $1.47K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 568 | $703 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 50 | $62 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 417 | $0 | 0.00% | +417 | New |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −272,193−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −271,400−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −244,875−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −102,961−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −57,933−100.0% | Sold out |
| Donald L. Hagan, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −14,064−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −12,514−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −2,565−100.0% | Sold out |
| Frazier Financial Advisors, LLC | 0 | $0 | 0.00% | −515−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −145−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |